All data are based on the daily closing price as of July 1, 2025
h
Humedix
200670.KQ
41.47 USD
-0.65
-1.54%
Overview
Last close
41.47 usd
Market cap
427.93M usd
52 week high
44.40 usd
52 week low
18.18 usd
Target price
41.76 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
5.3464
Price/Book Value
2.4633
Enterprise Value
344.13M usd
EV/Revenue
2.8948
EV/EBITDA
7.6564
Key financials
Revenue TTM
82.04M usd
Gross Profit TTM
32.57M usd
EBITDA TTM
20.89M usd
Earnings per Share
N/A usd
Dividend
0.49 usd
Total assets
180.56M usd
Net debt
N/A usd
About
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.